Companies acquiring technology from university researchers usually want to take over control of the work, to better manage its progress and direct it toward corporate goals, which can be far different from academic goals.

In the case of the TGF-Beta super-family of genes, however, Genetics Institute Inc. and The Johns Hopkins University School of Medicine decided that a more equal partnership would take advantage of both parties' strengths.